• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Development of novel anticancer drugs targeting for controlling the function and expression of oxidative stress-induced protein

Research Project

  • PDF
Project/Area Number 24790114
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Drug development chemistry
Research InstitutionGifu Pharmaceutical University

Principal Investigator

ENDO Satoshi  岐阜薬科大学, 薬学部, 助教 (60433207)

Project Period (FY) 2012-04-01 – 2014-03-31
Keywordsaldo-keto reductases / 抗癌剤 / 抗癌剤耐性抑制薬
Research Abstract

Aldo-keto reductases (AKR) which are induced by oxidative stress via Keap1/Nrf2 pathway are suggested to involve in proliferation and survival of cancer cells. Then, we searched novel AKR inhibitors for anticancer therapeutic development and have succeeded the development of the most potent and high selective AKR inhibitors and construction of AKR stably expressing cancer cells. These results would facilitate the development of novel anticancer drugs targeting for AKR.

  • Research Products

    (11 results)

All 2014 2013 2012 Other

All Journal Article (6 results) (of which Peer Reviewed: 4 results) Presentation (3 results) Remarks (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Cloning and characterization of four rabbit aldo-keto reductases featuring broad substrate specificity for xenobiotic and endogenous carbonyl compounds : Their relationship with multiple forms of drug ketone reductases2014

    • Author(s)
      Satoshi Endo, Toshiyuki Matsunaga, Yuki Arai, Kazuo Tajima, Ossama El-Kabbani, Shigeru Yamano, Yasuo Bunai, Akira Hara, Yukio Kitade
    • Journal Title

      Drug Metab. Dispos

      Volume: vol 42,No4 Pages: 803-812

    • DOI

      10.1124/dmd.113.056044

  • [Journal Article] Synthesis and structure-activity relationship of 2-phenylimino chromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10、Bioorg2014

    • Author(s)
      Satoshi Endo, Dawei Hu, Miho Suyama, Toshiyuki Matsunaga, Kenji Sugimoto, Yuji Matsuya, Ossama El-Kabbani, Kazuo Kuwata, Akira Hara, Yukio Kitade, Naoki Toyooka
    • Journal Title

      Med. Chem

      Volume: vol21 Pages: 6378-6384

    • DOI

      10.1016/j.bmc.2013.08.059

  • [Journal Article] Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin D2, and other endogenous and xenobiotic carbonyl compounds、Biochem2014

    • Author(s)
      Satoshi Endo, Toshiyuki Matsunaga, Atsuko Matsumoto, Yuki Arai, Satoshi Ohno, Ossama El-Kabbani, Kazuo Tajima, Yukio Kitade, Yasuo Bunai, Shigeru Yamano, and Akira
    • Journal Title

      Pharmacol

      Volume: Vol.86、No.9 Pages: 1366-1375

    • DOI

      10.1016/j.bcp.2013.08.024

    • Peer Reviewed
  • [Journal Article] Modulation of activity and inhibitor sensitivity of rabbit aldose reductase-like protein by oxidized glutathione and SH-reagents、Chem2013

    • Author(s)
      Satoshi Endo, Airi Fujimoto, Sho Kumada, Toshiyuki Matsunaga, Satoshi Ohno, Jun'ichi Mano, Kazuo Tajima, Ossama El-Kabbani, and Akira Hara
    • Journal Title

      Biol. Interact

      Volume: Vol. 202、No.1-3 Pages: 146-152

    • DOI

      10.1016/j.cbi.2012.11.026

    • Peer Reviewed
  • [Journal Article] Characterization of a rabbit morphine 6-dehydrogenase and its two isoforms which function as NAD+-dependent 3α(17β)- hydroxysteroid dehydrogenases2012

    • Author(s)
      Satoshi Endo, Toshiyuki Matsunaga, Airi Fujimoto, Sho Kumada, Yuki Arai, Yoko Miura, Hiroshige Mikamo, Ossama El-Kabbani, Shigeru Yamano, Munekazu Iinuma, Akira Hara
    • Journal Title

      Arch. Biochem. Biophys

      Volume: Vol.529、No.2 Pages: 131-139

    • DOI

      10.1016/j.abb.2012.11.013

    • Peer Reviewed
  • [Journal Article] Inhibition of Human Aldose Reductase-like Protein (AKR1B10) byα- andγ-Mangostins, Major Components of Pericarps of Mangosteen、Biol2012

    • Author(s)
      Midori Soda, Satoshi Endo, Toshiyuki Matsunaga, Hai-Tao Zhao, Ossama El-Kabbani, Munekazu Iinuma, Keiko Yamamura, and Akira Hara
    • Journal Title

      Pharm. Bull.

      Volume: Vol.35、No.11 Pages: 2075-2080

    • Peer Reviewed
  • [Presentation] 2-Phenyliminochromene誘導体の癌マーカーAKR1B10阻害活性に関する構造活性相関2013

    • Author(s)
      陶山美穂、遠藤智史、松永俊之、胡大イ、杉本健士、松谷裕二、豊岡尚樹、桑田一夫、原明
    • Organizer
      第41回構造活性相関シンポジウム
    • Place of Presentation
      兵庫
    • Year and Date
      2013-11-07
  • [Presentation] ウサギの3-hydroxyhexobarbital dehydrogenaseはketosteroids、prostaglandin D2、その他のカルボニル化合物に広い特異性を示す還元酵素である2013

    • Author(s)
      原明、遠藤智史、山野茂、松本淳子、荒井裕貴、松永俊之
    • Organizer
      第85回日本生化学会大会
    • Place of Presentation
      横浜
    • Year and Date
      2013-09-13
  • [Presentation] Ossama El-Kabbani, and Akira Hara、Modulation of activity and inhibitor sensitivity of rabbit aldose reductase-like protein by oxidized glutathione and SH-reagents2012

    • Author(s)
      Satoshi Endo, Sho Kumada, Airi Fujimoto, Toshiyuki Matsunaga, Satoshi Ohno, Jun'ichi Mano, Kazuo Tajima
    • Organizer
      ENZYMOLOGY AND MOLECULAR BIOLOGY OF CARBONYL METABOLISM SIXTEENTH INTERNATIONAL MEETING
    • Place of Presentation
      Plön, GERMANY
    • Year and Date
      20120714-15
  • [Remarks]

    • URL

      http://www.gifu-pu.ac.jp/lab/seika/index.html

  • [Patent(Industrial Property Rights)] AKR1C3阻害剤2013

    • Inventor(s)
      遠藤 智史、松永 俊之、豊岡 尚樹
    • Industrial Property Rights Holder
      岐阜市
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      特願2013-149089
    • Filing Date
      2013-07-18

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi